Detalles de la búsqueda
1.
Targeted Treatment against Cancer Stem Cells in Colorectal Cancer.
Int J Mol Sci
; 25(11)2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38892410
2.
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
Br J Cancer
; 126(6): 874-880, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937947
3.
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Br J Cancer
; 121(5): 378-383, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31363167
4.
In Vitro Anti-proliferative and Anti-invasive Effect of Polysaccharide-rich Extracts from Trametes Versicolor and Grifola Frondosa in Colon Cancer Cells.
Int J Med Sci
; 16(2): 231-240, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745803
5.
Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System.
J Proteome Res
; 16(8): 2773-2788, 2017 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28675930
6.
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.
BMC Cancer
; 15: 297, 2015 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25885099
7.
Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach.
Int J Mol Sci
; 16(6): 13610-32, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26084042
8.
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer.
Future Oncol
; 10(7): 1187-202, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947260
9.
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.
Clin Transl Oncol
; 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642257
10.
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Clin Transl Oncol
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578537
11.
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
Oncologist
; 17(3): 339-45, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22363067
12.
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
J Transl Med
; 10: 186, 2012 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22954417
13.
Circulating microRNAs: molecular microsensors in gastrointestinal cancer.
Sensors (Basel)
; 12(7): 9349-62, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23012546
14.
State of the art in silico tools for the study of signaling pathways in cancer.
Int J Mol Sci
; 13(6): 6561-6581, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22837650
15.
Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Int J Mol Sci
; 13(4): 4367-4387, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22605983
16.
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Eur J Surg Oncol
; 48(5): 1123-1132, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34872775
17.
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Eur J Cancer
; 177: 154-163, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335783
18.
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.
Cancers (Basel)
; 14(24)2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551560
19.
A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues.
Proteomics
; 11(12): 2555-9, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21591256
20.
A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens.
Invest New Drugs
; 29(5): 1021-8, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20127139